278 related articles for article (PubMed ID: 33755504)
1. Long-term effects of total skin electron beam therapy for mycosis fungoides on hair and nail loss and regrowth.
Breneman DL; Breneman A; Ballman E; Breneman JC
J Dermatolog Treat; 2022 Jun; 33(4):1975-1978. PubMed ID: 33755504
[TBL] [Abstract][Full Text] [Related]
2. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
Chinn DM; Chow S; Kim YH; Hoppe RT
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
[TBL] [Abstract][Full Text] [Related]
3. Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy.
Wilson LD; Licata AL; Braverman IM; Edelson RL; Heald PW; Feldman AM; Kacinski BM
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):987-95. PubMed ID: 7607973
[TBL] [Abstract][Full Text] [Related]
4. Changes in total skin electron beam therapy modalities for mycosis fungoides: A single-centre study.
Canu D; Pham-Ledard A; Ouhabrache N; Beylot-Barry M
Ann Dermatol Venereol; 2022 Sep; 149(3):180-184. PubMed ID: 35595588
[TBL] [Abstract][Full Text] [Related]
5. Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides.
An Y; Jiang W; Andraos TY; Reddy JP; Yehia ZA; Lloyd S; Duvic M; D'Souza NM; Milgrom SA; Pinnix CC; Oki Y; Smith GL; Wilson LD; Dabaja BS
Radiother Oncol; 2019 Feb; 131():88-92. PubMed ID: 30773193
[TBL] [Abstract][Full Text] [Related]
6. Total skin electron beam therapy (TSEBT) in management of mycosis fungoides: A case series.
Abrar S; Qureshi BM; Hafiz A; Ali N; Hammad Khan AM; Abbasi AN
J Pak Med Assoc; 2022 Jun; 72(6):1208-1210. PubMed ID: 35751338
[TBL] [Abstract][Full Text] [Related]
7. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
Hagedorn M; Hasche E; Kober B; Sander CA
Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
[TBL] [Abstract][Full Text] [Related]
8. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of mycosis fungoides management by total skin electron beam therapy with "translational technique".
Gamsiz H; Beyzadeoglu M; Sager O; Dincoglan F; Uysal B; Demiral S; Gundem E; Dirican B
J BUON; 2015; 20(4):1124-31. PubMed ID: 26416066
[TBL] [Abstract][Full Text] [Related]
10. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides).
Quirós PA; Jones GW; Kacinski BM; Braverman IM; Heald PW; Edelson RL; Wilson LD
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):1027-35. PubMed ID: 9276369
[TBL] [Abstract][Full Text] [Related]
11. Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
Lloyd S; Chen Z; Foss FM; Girardi M; Wilson LD
J Am Acad Dermatol; 2013 Oct; 69(4):537-43. PubMed ID: 23849563
[TBL] [Abstract][Full Text] [Related]
12. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study.
Yu JB; Khan AM; Jones GW; Reavely MM; Wilson LD
Am J Clin Oncol; 2009 Apr; 32(2):142-4. PubMed ID: 19307950
[TBL] [Abstract][Full Text] [Related]
13. Short-term efficacy and safety of total skin electron beam therapy in mycosis fungoides: Systematic review and meta-analysis.
Grandi V; Simontacchi G; Grassi T; Pileri A; Pimpinelli N
Dermatol Ther; 2022 Nov; 35(11):e15840. PubMed ID: 36124354
[TBL] [Abstract][Full Text] [Related]
14. Low-dose total skin electron beam therapy: Quality of life improvement and clinical impact of maintenance and adjuvant treatment in patients with mycosis fungoides or Sezary syndrome.
Elsayad K; Kroeger K; Greve B; Moustakis C; Assaf C; Stadler R; Lenz G; Weishaupt C; Eich HT
Strahlenther Onkol; 2020 Jan; 196(1):77-84. PubMed ID: 31591658
[TBL] [Abstract][Full Text] [Related]
15. Total Skin Electron Beam Therapy in the Treatment of Mycosis Fungoides: A Review of Conventional and Low-Dose Regimens.
Chowdhary M; Chhabra AM; Kharod S; Marwaha G
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):662-671. PubMed ID: 27692530
[TBL] [Abstract][Full Text] [Related]
16. Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II clinical trials.
Hoppe RT; Harrison C; Tavallaee M; Bashey S; Sundram U; Li S; Million L; Dabaja B; Gangar P; Duvic M; Kim YH
J Am Acad Dermatol; 2015 Feb; 72(2):286-92. PubMed ID: 25476993
[TBL] [Abstract][Full Text] [Related]
17. A prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life.
Song A; Gochoco A; Zhan T; Sahu J; Alpdogan O; Porcu P; Nikbakht N; Shi W
J Am Acad Dermatol; 2020 Jul; 83(1):78-85. PubMed ID: 32004646
[TBL] [Abstract][Full Text] [Related]
18. Low-dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T-cell lymphoma.
Elsayad K; Rolf D; Sunderkötter C; Weishaupt C; Müller EC; Nawar T; Stranzenbach R; Livingstone E; Stadler R; Steinbrink K; Moritz RKC; Eich HT
J Dtsch Dermatol Ges; 2022 Mar; 20(3):279-285. PubMed ID: 34984837
[TBL] [Abstract][Full Text] [Related]
19. Total Skin Electron Beam Therapy for Mycosis Fungoides Revisited With Adjuvant Systemic Therapy.
Rivers CI; Singh AK
Clin Lymphoma Myeloma Leuk; 2019 Feb; 19(2):83-88. PubMed ID: 30528417
[TBL] [Abstract][Full Text] [Related]
20. Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment.
Jennings T; Duffy R; Gochoco A; Knoblauch K; Shi W; Alpdogan SO; Porcu P; Werner-Wasik M; Sahu J
Chin Clin Oncol; 2019 Feb; 8(1):13. PubMed ID: 30525753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]